4th Alzheimer's Awards Announced

19 July 2011 - For the fourth year, the Fondation Médéric Alzheimer and Alzheimer’s Disease International (ADI) are running Alzheimer's Awards for evidence-based psychosocial interventions for people with dementia and their carers. The purpose of the Award is to promote better care and share best practices. Applications can be submitted from today 19 July until 1 December 2011.

Psychosocial research involves or relates to both the social and psychological aspects of a patient's life. Often this includes the relationship between the personal, internal environment and the wider social world, such as the influence of social and environmental factors on an individual's state of mind or behaviour. This type of research is aimed at supporting and enhancing the quality of life of people with Alzheimer’s disease and their carers.

Two Alzheimer’s Awards will be given, the first for the best evidence-based psychosocial intervention. The €18,000 award is intended to be used for dissemination of the research findings to a broad range of organisations and people involved in dementia treatment and care worldwide and in several languages.

The second Alzheimer’s Award, of €7,000, will be given for the most promising evidence-based psychosocial intervention and is intended to be used to further implement a project that has already shown some results but that needs more thorough evaluation.

Previous winners of the award include:

  • Dr Mary Mittelman of the NYU School of Medicine, USA
  • Daniel George on behalf of The Intergenerational School in the USA
  • Dr Amit Dias from The Dementia Society of Goa in India
  • Prof Anne Margriet Pot, Head of the Netherlands Institute of Mental Health and Addiction Program on Aging
  • Prof Sube Banerjee of the Institute of Psychiatry, Kings College London, UK

All project proposals and complete application forms should be submitted by email before 1 December 2011. The winners will receive their awards during the 27th International Conference of Alzheimer’s Disease International in London, UK in March 2012.

Dementia is a syndrome that can be caused by a number of progressive disorders that affect memory, thinking, behavior and the ability to perform everyday activities. Alzheimer’s disease is the most common type of dementia. Approximately 0.5% of the world’s total population live with dementia and this will grow exponentially.

After age 65, the likelihood of developing dementia roughly doubles every five years. At the age of 85, the odds of a person developing it are close to 50 percent. In the World Alzheimer Report 2010, ADI estimated that there are 35.6 million people living with dementia worldwide, increasing to 65.7 million by 2030 and 115.4 million by 2050. The worldwide costs of dementia exceeds 1% of global GDP, at US$604 billion.

Details of the award and how to enter may be found here.

The Fondation Médéric Alzheimer is a non-profit organisation that was created in 1999. It aims to increase the knowledge in social sciences related to Alzheimer’s disease, to support and promote innovative field projects intended in helping people with Alzheimer’s disease and their carers, and to instigate national surveys allowing the analysis of yearly evolutions and geographic disparities. The Fondation organises its support and research actions along three axes: (1) Observe, identify and understand, (2) Inspire, support and sustain and (3) Raise awareness and make available information and state of the art.

Alzheimer's Disease International was established in 1984. Just over 25 years later Alzheimer's Disease International is now the international federation of 76 Alzheimer associations around the world, and in official relations with the World Health Organisation. It is an internationally recognised organisation with a range of activities and events. Each member is the Alzheimer association in their country who support people with dementia and their families. Alzheimer's Disease International aims to help establish and strengthen Alzheimer associations throughout the world, and to raise global awareness about Alzheimer's disease and all other causes of dementia.